{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:22:12Z","timestamp":1783502532199,"version":"3.55.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell&apos;Istruzione dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lfs.2025.124075","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:53:21Z","timestamp":1762502001000},"page":"124075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Drug enteric metabolism in gut microbiota-brain crosstalk"],"prefix":"10.1016","volume":"383","author":[{"given":"Samuele","family":"Maramai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Castagnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Viciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini-Dionysia","family":"Koufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Boschetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Calandra-Buonaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Sambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Scorziello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taglialatela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Corsaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/cpt.757","article-title":"The role of the kidney in drug elimination: transport, metabolism, and the impact of kidney disease on drug clearance","volume":"102","author":"Miners","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/17425255.2021.1908262","article-title":"Drug metabolism in the lungs: opportunities for optimising inhaled medicines","volume":"17","author":"Enlo-Scott","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/dmd.108.024794","article-title":"Biotransformation of drugs in human skin","volume":"37","author":"Svensson","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1389557522666220622111501","article-title":"Microbiota-gut-brain axis in neurological disorders: from leaky barriers microanatomical changes to biochemical processes","volume":"23","author":"Neri","year":"2023","journal-title":"Mini-Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0030","first-page":"2937","article-title":"The expanding burden of neurodegenerative diseases: an unmet medical and social need","volume":"16","author":"Wang","year":"2024","journal-title":"Aging Dis."},{"issue":"8","key":"10.1016\/j.lfs.2025.124075_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome\u2013gut\u2013brain axis in parkinson disease \u2014 from basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2025.124075_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105314","article-title":"The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology","volume":"164","author":"Doifode","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12868-025-00953-9","article-title":"Gut microbiome rewiring via fecal transplants: uncovering therapeutic avenues in Alzheimer\u2019s disease models","volume":"26","author":"Upadhyay","year":"2025","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0050","article-title":"Reduction of abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota","volume":"7","author":"Harach","year":"2017","journal-title":"Sci. Rep."},{"issue":"31","key":"10.1016\/j.lfs.2025.124075_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba0466","article-title":"Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model","volume":"6","author":"Chen","year":"2020","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.lfs.2025.124075_bb0060","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.lfs.2025.124075_bb0065","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/apm.13225","article-title":"The human microbiome in disease and pathology","volume":"130","author":"Manos","year":"2022","journal-title":"APMIS"},{"issue":"13","key":"10.1016\/j.lfs.2025.124075_bb0070","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","article-title":"The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"Brown","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000481519","article-title":"Gut microbiota-dependent modulation of energy metabolism","volume":"10","author":"Heiss","year":"2018","journal-title":"J. Innate Immun."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.chom.2013.09.012","article-title":"Microbial modulation of energy availability in the colon regulates intestinal transit","volume":"14","author":"Wichmann","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"20","key":"10.1016\/j.lfs.2025.124075_bb0085","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.3390\/app14209383","article-title":"Gut microbiota as an endocrine organ: unveiling its role in human physiology and health","volume":"14","author":"Pires","year":"2024","journal-title":"Appl. Sci."},{"key":"10.1016\/j.lfs.2025.124075_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2012.03916.x","article-title":"The microbiome as a human organ","volume":"18","author":"Baquero","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0095","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1042\/BST20201201","article-title":"Relationship between mucosa-associated gut microbiota and human diseases","volume":"50","author":"Juge","year":"2022","journal-title":"Biochem. Soc. Trans."},{"issue":"9","key":"10.1016\/j.lfs.2025.124075_bb0100","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1021\/acsnano.0c05426","article-title":"An ingestible self-polymerizing system for targeted sampling of gut microbiota and biomarkers","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.lfs.2025.124075_bb0105","doi-asserted-by":"crossref","unstructured":"Fock, E.; Parnova, R. Mechanisms of Blood\u2013Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids. Cells 2023, 12 (4), 657. doi: https:\/\/doi.org\/10.3390\/cells12040657.","DOI":"10.3390\/cells12040657"},{"key":"10.1016\/j.lfs.2025.124075_bb0110","doi-asserted-by":"crossref","unstructured":"Chakrabarti, A.; Geurts, L.; Hoyles, L.; Iozzo, P.; Kraneveld, A. D.; La Fata, G.; Miani, M.; Patterson, E.; Pot, B.; Shortt, C.; Vauzour, D. The Microbiota\u2013Gut\u2013Brain Axis: Pathways to Better Brain Health. Perspectives on What We Know, What We Need to Investigate and How to Put Knowledge into Practice. Cellular and Molecular Life Sciences 2022, 79 (2), 80. doi: https:\/\/doi.org\/10.1007\/s00018-021-04060-w.","DOI":"10.1007\/s00018-021-04060-w"},{"key":"10.1016\/j.lfs.2025.124075_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnsys.2013.00009","article-title":"Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study","volume":"7","author":"Matsumoto","year":"2013","journal-title":"Front. Syst. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12904","article-title":"GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine","volume":"29","author":"Pokusaeva","year":"2017","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.lfs.2025.124075_bb0125","first-page":"9","article-title":"A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols","author":"Maini Rekdal","year":"2020","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/a-2536-1421","article-title":"Gut microbial control of neurotransmitters and their relation to neurological disorders: a comprehensive review","volume":"57","author":"Gurow","year":"2025","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/nu8010056","article-title":"Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis","volume":"8","author":"Jenkins","year":"2016","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/cells14050384","article-title":"Tryptophan and its metabolite serotonin impact metabolic and mental disorders via the brain\u2013gut\u2013microbiome axis: a focus on sex differences","volume":"14","author":"Xu","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s42003-024-06330-2","article-title":"Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: implications in Parkinson\u2019s disease","volume":"7","author":"Cheng","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lfs.2025.124075_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1098412","article-title":"Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?","volume":"14","author":"Miri","year":"2023","journal-title":"Front. Microbiol."},{"issue":"22","key":"10.1016\/j.lfs.2025.124075_bb0160","first-page":"10","article-title":"Dietary co-metabolism within the microbiota-gut-brain-endocrine metabolic interactome","volume":"2","author":"Obrenovich","year":"2017","journal-title":"BAO Microbiol."},{"key":"10.1016\/j.lfs.2025.124075_bb0165","doi-asserted-by":"crossref","unstructured":"Schiera, G.; Di Liegro, C. M.; Schir\u00f2, G.; Sorbello, G.; Di Liegro, I. Involvement of Astrocytes in the Formation, Maintenance, and Function of the Blood\u2013Brain Barrier. Cells 2024, 13 (2), 150. doi: https:\/\/doi.org\/10.3390\/cells13020150.","DOI":"10.3390\/cells13020150"},{"issue":"8","key":"10.1016\/j.lfs.2025.124075_bb0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/labinvest.3700600","article-title":"Starring roles for astroglia in barrier pathologies of gut and brain","volume":"87","author":"Savidge","year":"2007","journal-title":"Lab. Invest."},{"key":"10.1016\/j.lfs.2025.124075_bb0175","article-title":"Enteric glial cells in immunological disorders of the gut","volume":"16","author":"Liu","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2025.124075_bb0180","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2014.09.040","article-title":"Enteric glial cells: recent developments and future directions","volume":"147","author":"Neunlist","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.lfs.2025.124075_bb0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41575-023-00890-0","article-title":"Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota\u2013gut\u2013brain axis","volume":"21","author":"Aburto","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0190","first-page":"1108","article-title":"Microbiota-gut-brain axis dysregulation in Alzheimer\u2019s disease: multi-pathway effects and therapeutic potential","volume":"15","author":"Qu","year":"2023","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cns.13990","article-title":"Gut bacterial profiles in Parkinson\u2019s disease: a systematic review","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2025.124075_bb0200","doi-asserted-by":"crossref","unstructured":"Klann, E. M.; Dissanayake, U.; Gurrala, A.; Farrer, M.; Shukla, A. W.; Ramirez-Zamora, A.; Mai, V.; Vedam-Mai, V. The Gut\u2013Brain Axis and Its Relation to Parkinson's Disease: A Review. Front. Aging Neurosci. 2022, 13, 782082. doi: https:\/\/doi.org\/10.3389\/fnagi.2021.782082.","DOI":"10.3389\/fnagi.2021.782082"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2025.124075_bb0210","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mdc3.70029","article-title":"The gut-brain axis in parkinson disease: emerging concepts and therapeutic implications","volume":"12","author":"Menozzi","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-023-01218-5","article-title":"A peripheral signature of Alzheimer\u2019s disease featuring microbiota-gut-brain axis markers","volume":"15","author":"Marizzoni","year":"2023","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.lfs.2025.124075_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107693","article-title":"From gut to brain: the role of gut dysbiosis, bacterial amyloids, and metabolic disease in Alzheimer\u2019s disease","volume":"215","author":"Inan","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"21","key":"10.1016\/j.lfs.2025.124075_bb0225","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.3390\/cells11213468","article-title":"Rifaximin modifies gut microbiota and attenuates inflammation in Parkinson\u2019s disease: preclinical and clinical studies","volume":"11","author":"Hong","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40168-020-00988-6","article-title":"Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Hou","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01191-21","article-title":"Parkinson\u2019s Disease medication alters small intestinal motility and microbiota composition in healthy rats","volume":"7","author":"van Kessel","year":"2022","journal-title":"mSystems"},{"key":"10.1016\/j.lfs.2025.124075_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuroscience.2025.04.050","article-title":"Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson\u2019s disease","volume":"576","author":"Rust","year":"2025","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.lfs.2025.124075_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14846","article-title":"Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson\u2019s disease patients","volume":"36","author":"Gorecka-Mazur","year":"2024","journal-title":"Neurogastroenterol. Motil."},{"issue":"4","key":"10.1016\/j.lfs.2025.124075_bb0250","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/ene.14644","article-title":"Gut microbiota and metabolome distinctive features in parkinson disease: focus on levodopa and levodopa-carbidopa intrajejunal gel","volume":"28","author":"Melis","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.lfs.2025.124075_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.574529","article-title":"Effect of levodopa initiation on the gut microbiota in Parkinson\u2019s disease","volume":"12","author":"Palacios","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2025.124075_bb0260","series-title":"Metalloenzymes","first-page":"63","article-title":"Catechol-O-methyltransferase (COMT)","author":"Tassone","year":"2024"},{"key":"10.1016\/j.lfs.2025.124075_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.837019","article-title":"A pilot study exploring the association of entacapone, gut microbiota, and the subsequent side effects in patients with Parkinson\u2019s disease","volume":"12","author":"Fu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.lfs.2025.124075_bb0270","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1038\/s41564-024-01853-0","article-title":"The Parkinson\u2019s disease drug entacapone disrupts gut microbiome homeostasis via iron sequestration","volume":"9","author":"Pereira","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.lfs.2025.124075_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2022.103041","article-title":"The multiple roles of dopamine receptor activation in the modulation of gastrointestinal motility and mucosal function","volume":"244","author":"Serio","year":"2023","journal-title":"Auton. Neurosci."},{"issue":"10","key":"10.1016\/j.lfs.2025.124075_bb0280","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D 2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J. Neurosci."},{"issue":"19","key":"10.1016\/j.lfs.2025.124075_bb0285","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.3390\/molecules27196591","article-title":"Effects of donepezil treatment on brain metabolites, gut microbiota, and gut metabolites in an amyloid beta-induced cognitive impairment mouse pilot model","volume":"27","author":"Jo","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41387-020-0115-8","article-title":"Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Ou","year":"2020","journal-title":"Nutr. Diabetes"},{"issue":"9","key":"10.1016\/j.lfs.2025.124075_bb0295","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/microorganisms11092306","article-title":"Impact of donepezil supplementation on Alzheimer\u2019s disease-like pathology and gut microbiome in APP\/PS1 mice","volume":"11","author":"Li","year":"2023","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0300","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/ijms22031015","article-title":"Influence of acetylcholine esterase inhibitors and memantine, clinically approved for Alzheimer\u2019s dementia treatment, on intestinal properties of the mouse","volume":"22","author":"Nguyen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0305","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/aging.102645","article-title":"Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP\/PS1 mice","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"issue":"6445","key":"10.1016\/j.lfs.2025.124075_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism","volume":"364","author":"Maini Rekdal","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0315","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14383","article-title":"Piperine improves levodopa availability in the 6-OHDA-lesioned rat model of Parkinson\u2019s disease by suppressing gut bacterial tyrosine decarboxylase","volume":"30","author":"Hu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0325","doi-asserted-by":"crossref","first-page":"26146","DOI":"10.1038\/s41598-024-77038-w","article-title":"Bacteriophages targeting enterococcus faecalis enhance the therapeutic efficacy of levodopa in an MPTP-induced Parkinson\u2019s disease mouse model with E. FAECALIS gut colonization","volume":"14","author":"Hong","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0330","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3988\/jcn.2017.13.2.181","article-title":"Association of Helicobacter pylori with Parkinson\u2019s disease","volume":"13","author":"Mridula","year":"2017","journal-title":"J. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251042","article-title":"Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson\u2019s disease patients: a prospective cohort study (HP-PD trial)","volume":"16","author":"Lolekha","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2025.124075_bb0340","doi-asserted-by":"crossref","unstructured":"Niehues, M.; Hensel, A. In-Vitro Interaction of L-Dopa with Bacterial Adhesins of <I>Helicobacter Pylori:<\/I> an Explanation for Clinicial Differences in Bioavailability? J. Pharm. Pharmacol. 2009, 61 (10), 1303\u20131307. doi: https:\/\/doi.org\/10.1211\/jpp\/61.10.0005.","DOI":"10.1211\/jpp\/61.10.0005"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12915-020-00876-3","article-title":"Gut bacterial deamination of residual levodopa medication for Parkinson\u2019s disease","volume":"18","author":"van Kessel","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.lfs.2025.124075_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1046910","article-title":"A review of studies on gut microbiota and levodopa metabolism","volume":"14","author":"Zhong","year":"2023","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0355","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/nu12051389","article-title":"Acetyl-L-carnitine in dementia and other cognitive disorders: a critical update","volume":"12","author":"Pennisi","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0360","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","article-title":"Statins: multiple neuroprotective mechanisms in neurodegenerative diseases","volume":"230","author":"Wang","year":"2011","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.lfs.2025.124075_bb0365","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/microorganisms12061133","article-title":"Simvastatin, its antimicrobial activity and its prevention of Alzheimer\u2019s disease","volume":"12","author":"Dhakal","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.lfs.2025.124075_bb0370","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231156674","article-title":"Microglia as a cellular target of diclofenac therapy in Alzheimer\u2019s disease","volume":"16","author":"Stopschinski","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0375","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2013.10.013","article-title":"Gut microbiota metabolism of L-carnitine and cardiovascular risk","volume":"231","author":"Ussher","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2025.124075_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105874","article-title":"Acetyl-L-carnitine in chronic pain: a narrative review","volume":"173","author":"Sarzi-Puttini","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0385","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmet.2012.04.005","article-title":"Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility","volume":"15","author":"Muoio","year":"2012","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155694","article-title":"Serum levels of acyl-carnitines along the continuum from normal to Alzheimer\u2019s dementia","volume":"11","author":"Cristofano","year":"2016","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.lfs.2025.124075_bb0395","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/nu12071987","article-title":"Preventive role of L-carnitine and balanced diet in Alzheimer\u2019s disease","volume":"12","author":"Kepka","year":"2020","journal-title":"Nutrients"},{"issue":"34","key":"10.1016\/j.lfs.2025.124075_bb0400","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1074\/jbc.M109.032888","article-title":"Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control","volume":"284","author":"Noland","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2025.124075_bb0405","series-title":"Natural Molecules in Neuroprotection and Neurotoxicity","first-page":"475","article-title":"Endogenous Molecules in Neuroprotection: Acetyl-L-Carnitine","author":"Maldonado","year":"2024"},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0410","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0304-3940(02)00667-5","article-title":"Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons","volume":"329","author":"Bigini","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2025.124075_bb0415","first-page":"13","article-title":"Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain","author":"Notartomaso","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2025.124075_bb0420","doi-asserted-by":"crossref","unstructured":"Spagnoli, A.; Lucca, U.; Menasce, G.; Bandera, L.; Cizza, G.; Forloni, G.; Tettamanti, M.; Frattura, L.; Tiraboschi, P.; Comelli, M.; Senin, U.; Longo, A.; Petrini, A.; Brambilla, G.; Belloni, A.; Negri, C.; Cavazzuti, F.; Salsi, A.; Calogero, P.; Parma, E.; Stramba-Badiale, M.; Vitali, S.; Andreoni, G.; Inzoli, M. R.; Santus, G.; Caregnato, R.; Peruzza, M.; Favaretto, M.; Bozeglav, C.; Alberoni, M.; Leo, D. De; Serraiotto, L.; Baiocchi, A.; Scoccia, S.; Culotta, P.; Ieracitano, D. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 1991, 41 (11), 1726\u20131726. doi: https:\/\/doi.org\/10.1212\/WNL.41.11.1726.","DOI":"10.1212\/WNL.41.11.1726"},{"issue":"11","key":"10.1016\/j.lfs.2025.124075_bb0425","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneur.1992.00530350051019","article-title":"Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer\u2019s disease","volume":"49","author":"Sano","year":"1992","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2025.124075_bb0430","first-page":"306","article-title":"Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia","volume":"12","author":"Campi","year":"1990","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.lfs.2025.124075_bb0435","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1185\/03007999009112690","article-title":"Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer\u2019s dementia","volume":"11","author":"Rai","year":"1990","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.lfs.2025.124075_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2017.02.007","article-title":"Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson\u2019s disease in the rat","volume":"89","author":"Afshin-Majd","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0445","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pbb.2011.09.002","article-title":"Acetyl-l-carnitine and \u03b1-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson\u2019s disease therapy","volume":"100","author":"Zaitone","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2025.124075_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114848","article-title":"Chronic acetyl-L-carnitine treatment alleviates behavioral deficits and neuroinflammation through enhancing microbiota derived-SCFA in valproate model of autism","volume":"163","author":"Zahedi","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0455","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.foodchem.2007.01.058","article-title":"The determination of L-carnitine in several food samples","volume":"105","author":"Seline","year":"2007","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00415004","article-title":"Assimilation of \u03b3-butyrobetaine, and D-and L-carnitine by resting cell suspensions of Acinetobacter calcoaceticus and Pseudomonas putida","volume":"133","author":"Miura-Fraboni","year":"1982","journal-title":"Arch. Microbiol."},{"issue":"11","key":"10.1016\/j.lfs.2025.124075_bb0465","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1073\/pnas.1316569111","article-title":"Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota","volume":"111","author":"Zhu","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.1997.tb10212.x","article-title":"Bacterial carnitine metabolism","volume":"147","author":"Kleber","year":"2006","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0475","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00690825","article-title":"Stimulation of the anaerobic growth of Salmonella typhimurium by reduction Ofl-carnitine, carnitine derivatives and structure-related trimethylammonium compounds","volume":"132","author":"Seim","year":"1982","journal-title":"Arch. Microbiol."},{"issue":"32","key":"10.1016\/j.lfs.2025.124075_bb0480","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101498118","article-title":"Elucidation of an anaerobic pathway for metabolism of L-carnitine\u2013derived \u03b3-butyrobetaine to trimethylamine in human gut bacteria","volume":"118","author":"Rajakovich","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"20","key":"10.1016\/j.lfs.2025.124075_bb0485","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1021\/acs.jafc.9b08313","article-title":"High L-carnitine ingestion impairs liver function by disordering gut bacteria composition in mice","volume":"68","author":"Wu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2025.124075_bb0490","doi-asserted-by":"crossref","unstructured":"Hulme, H.; Meikle, L. M.; Strittmatter, N.; van der Hooft, J. J. J.; Swales, J.; Bragg, R. A.; Villar, V. H.; Ormsby, M. J.; Barnes, S.; Brown, S. L.; Dexter, A.; Kamat, M. T.; Komen, J. C.; Walker, D.; Milling, S.; Osterweil, E. K.; MacDonald, A. S.; Schofield, C. J.; Tardito, S.; Bunch, J.; Douce, G.; Edgar, J. M.; Edrada-Ebel, R.; Goodwin, R. J. A.; Burchmore, R.; Wall, D. M. Microbiome-Derived Carnitine Mimics as Previously Unknown Mediators of Gut-Brain Axis Communication. Sci Adv 2020, 6 (11), eaax6328. doi: https:\/\/doi.org\/10.1126\/sciadv.aax6328.","DOI":"10.1126\/sciadv.aax6328"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2025.124075_bb0495","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: in vitro and in vivo antibacterial activity \u2013 a review","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0500","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0505","article-title":"Probing gut-brain links in Alzheimer\u2019s disease with rifaximin","volume":"8","author":"Suhocki","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0510","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1038\/s41598-021-83994-4","article-title":"Effects of the antibiotic rifaximin on cortical functional connectivity are mediated through insular cortex","volume":"11","author":"Sometti","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0515","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12974-021-02303-y","article-title":"Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat","volume":"18","author":"Li","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2025.124075_bb0520","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jad.2023.02.086","article-title":"Rifaximin ameliorates depression-like behaviour in chronic unpredictable mild stress rats by regulating intestinal microbiota and hippocampal tryptophan metabolism","volume":"329","author":"Cheng","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.lfs.2025.124075_bb0525","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.hlc.2023.04.300","article-title":"The effects of statins on cardiovascular and inflammatory biomarkers in primary prevention: a systematic review and meta-analysis","volume":"32","author":"He","year":"2023","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.lfs.2025.124075_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114611","article-title":"Simvastatin improves learning and memory impairment via gut-brain axis regulation in an ovariectomized\/D-galactose Alzheimer\u2019s rat model","volume":"453","author":"Zahedi","year":"2023","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0535","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12979-022-00311-x","article-title":"Long-term atorvastatin improves cognitive decline by regulating gut function in naturally ageing rats","volume":"19","author":"Xu","year":"2022","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.lfs.2025.124075_bb0540","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2020.11.032","article-title":"Atorvastatin alleviates microglia-mediated neuroinflammation via modulating the microbial composition and the intestinal barrier function in ischemic stroke mice","volume":"162","author":"Zhang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2025.124075_bb0545","first-page":"10","article-title":"Alterations in gut microbiota by statin therapy and possible intermediate effects on hyperglycemia and hyperlipidemia","volume":"2019","author":"Kim","year":"1947","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2025.124075_bb0550","doi-asserted-by":"crossref","unstructured":"Khan, T. J.; Ahmed, Y. M.; Zamzami, M. A.; Siddiqui, A. M.; Khan, I.; Baothman, O. A. S.; Mehanna, M. G.; kuerban, A.; Kaleemuddin, M.; Yasir, M. Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients. Omics 2018, 22 (2), 154\u2013163. doi: https:\/\/doi.org\/10.1089\/omi.2017.0130.","DOI":"10.1089\/omi.2017.0130"},{"issue":"5","key":"10.1016\/j.lfs.2025.124075_bb0555","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","article-title":"Statin use and risk of dementia or Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"29","author":"Olmastroni","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0560","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00415-012-6606-3","article-title":"Statin use and risk of Parkinson\u2019s disease: a meta-analysis of observational studies","volume":"260","author":"Undela","year":"2013","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152564","article-title":"Statin use and the risk of Parkinson\u2019s disease: an updated meta-analysis","volume":"11","author":"Bai","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2025.124075_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1103836","article-title":"Butyrate producers, \u201cThe Sentinel of Gut\u201d: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics","volume":"13","author":"Singh","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2025.124075_bb0575","doi-asserted-by":"crossref","unstructured":"Silveira, A. K.; Gomes, H. M.; Fr\u00f6hlich, N. Thais.; Possa, L.; Santos, L.; Kessler, F.; Martins, A.; Rodrigues, M. S.; De Oliveira, J.; do Nascimento, N. D.; Sirena, D.; Paz, A. H.; Gelain, D. Pens.; Moreira, J. C. F. Sodium butyrate protects against intestinal oxidative damage and neuroinflammation in the prefrontal cortex of ulcerative colitis mice model. Immunol. Invest. 2023, 52 (7), 796\u2013814. doi: https:\/\/doi.org\/10.1080\/08820139.2023.2244967.","DOI":"10.1080\/08820139.2023.2244967"},{"issue":"4","key":"10.1016\/j.lfs.2025.124075_bb0580","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.14336\/AD.2021.1215","article-title":"Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer\u2019s disease","volume":"13","author":"Qian","year":"2022","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0585","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/C0MB00023J","article-title":"Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro","volume":"7","author":"Aura","year":"2011","journal-title":"Mol. Biosyst."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0590","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/s41598-022-08804-x","article-title":"Detection and characterization of simvastatin and its metabolites in rat tissues and biological fluids using MALDI high resolution mass spectrometry approach","volume":"12","author":"Yin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.124075_bb0595","doi-asserted-by":"crossref","unstructured":"Yoo, D.-H.; Kim, I. S.; Van Le, T. K.; Jung, I.-H.; Yoo, H. H.; Kim, D.-H. Gut microbiota-mediated drug interactions between lovastatin and antibiotics. Drug Metab. Dispos. 2014, 42 (9), 1508\u20131513. doi: https:\/\/doi.org\/10.1124\/dmd.114.058354.","DOI":"10.1124\/dmd.114.058354"},{"issue":"11","key":"10.1016\/j.lfs.2025.124075_bb0600","first-page":"850","article-title":"Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent","volume":"22","author":"Skoutakis","year":"1988","journal-title":"Drug Intell. Clin. Pharm."},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0605","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40122-018-0100-2","article-title":"A review of chronic musculoskeletal pain: central and peripheral effects of diclofenac","volume":"7","author":"Atzeni","year":"2018","journal-title":"Pain Ther."},{"issue":"7","key":"10.1016\/j.lfs.2025.124075_bb0610","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","article-title":"Diclofenac: an update on its mechanism of action and safety profile","volume":"26","author":"Gan","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.lfs.2025.124075_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128130","article-title":"Effescts of acute diclofenac exposure on intestinal histology, antioxidant defense, and microbiota in freshwater crayfish (Procambarus clarkii)","volume":"263","author":"Zhang","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.lfs.2025.124075_bb0620","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","article-title":"NSAID\u2013gut microbiota interactions","volume":"11","author":"Maseda","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2025.124075_bb0625","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3389\/fphar.2018.01340","article-title":"Pathophysiology of NSAID-associated intestinal lesions in the rat: luminal bacteria and mucosal inflammation as targets for prevention","volume":"9","author":"Colucci","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2025.124075_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108327","article-title":"Interactions between NSAIDs, opioids and the gut microbiota - future perspectives in the management of inflammation and pain","volume":"241","author":"Z\u00e1dori","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2025.124075_bb0635","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420935676","article-title":"Diclofenac reduces the risk of Alzheimer\u2019s disease: a pilot analysis of NSAIDs in two US veteran populations","volume":"13","author":"Stuve","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.lfs.2025.124075_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2016.10.003","article-title":"Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer\u2019s disease: a bioinformatics approach","volume":"15","author":"Nevado-Holgado","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.lfs.2025.124075_bb0645","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.neuropharm.2007.11.010","article-title":"Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for \u03b1-synuclein fibrils in vitro","volume":"54","author":"Hirohata","year":"2008","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0650","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00204-014-1242-6","article-title":"Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites","volume":"89","author":"Niu","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0655","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cpt.2907","article-title":"Intestinal metabolism of diclofenac by polymorphic UGT2B17 correlates with its highly variable pharmacokinetics and safety across populations","volume":"114","author":"Ahire","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2025.124075_bb0660","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00498254.2013.811314","article-title":"Bacterial \u03b2-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics","volume":"44","author":"Saitta","year":"2014","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.lfs.2025.124075_bb0665","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/jpet.111.191122","article-title":"Pharmacologic targeting of bacterial \u03b2-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice","volume":"341","author":"LoGuidice","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2025.124075_bb0670","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/bjs5.63","article-title":"Experimental study of diclofenac and its biliary metabolites on anastomotic healing","volume":"2","author":"Yauw","year":"2018","journal-title":"BJS Open"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525007118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525007118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T21:08:43Z","timestamp":1766092123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525007118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":134,"alternative-id":["S0024320525007118"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124075","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug enteric metabolism in gut microbiota-brain crosstalk","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.124075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"124075"}}